A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis
A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis. // Materials Today Bio. – URL: https://www.sciencedirect.com/science/article/pii/S2590006426010501?dgcid=rss_sd_all
A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis. Materials Today Bio. https://www.sciencedirect.com/science/article/pii/S2590006426010501?dgcid=rss_sd_all
“A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis.” Materials Today Bio.
@article{article5256,
title = {A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis},
journal = {Materials Today Bio},
url = {https://www.sciencedirect.com/science/article/pii/S2590006426010501?dgcid=rss_sd_all}
}